Leo’s Tralokinumab Among 11 New Approval Hopefuls In EU
Athenex/Almirall’s Tirbanibulin May Also Get A Thumbs Up
The developers of eleven new drugs could learn this week whether the European Medicines Agency will set them on course for pan-EU marketing approval.
You may also be interested in...
The European Medicines Agency today announced the new medicines it believes should be approved for use across the EU.
Odevixibat, which could become the first drug approved for treating progressive familial intrahepatic cholestasis in children, is up for an opinion from the European Medicines Agency.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker